EE05329B1 - GlyT-1 inhibiitorid, neid sisaldavad kompositsioonid, nende kasutamine ja nende valmistamise vahehendid - Google Patents

GlyT-1 inhibiitorid, neid sisaldavad kompositsioonid, nende kasutamine ja nende valmistamise vahehendid

Info

Publication number
EE05329B1
EE05329B1 EEP200300394A EEP200300394A EE05329B1 EE 05329 B1 EE05329 B1 EE 05329B1 EE P200300394 A EEP200300394 A EE P200300394A EE P200300394 A EEP200300394 A EE P200300394A EE 05329 B1 EE05329 B1 EE 05329B1
Authority
EE
Estonia
Prior art keywords
glyt
intermediates
inhibitors
preparation
compositions containing
Prior art date
Application number
EEP200300394A
Other languages
English (en)
Estonian (et)
Inventor
Egle Ian
Delaney William
Wang Zhaoqing
Shumacher Richard
T. Hopper Allen
Tehim Ashok
Maddaford Shawn
Original Assignee
Allelix Neuroscience, Inc.
Nps Allelix Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23026417&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE05329(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allelix Neuroscience, Inc., Nps Allelix Corp. filed Critical Allelix Neuroscience, Inc.
Publication of EE200300394A publication Critical patent/EE200300394A/xx
Publication of EE05329B1 publication Critical patent/EE05329B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Epoxy Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
EEP200300394A 2001-02-16 2002-02-15 GlyT-1 inhibiitorid, neid sisaldavad kompositsioonid, nende kasutamine ja nende valmistamise vahehendid EE05329B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26924101P 2001-02-16 2001-02-16
PCT/CA2002/000176 WO2002066456A2 (en) 2001-02-16 2002-02-15 Thiophene substituted amine derivatives as glyt-1 inhibitors

Publications (2)

Publication Number Publication Date
EE200300394A EE200300394A (et) 2003-12-15
EE05329B1 true EE05329B1 (et) 2010-08-16

Family

ID=23026417

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300394A EE05329B1 (et) 2001-02-16 2002-02-15 GlyT-1 inhibiitorid, neid sisaldavad kompositsioonid, nende kasutamine ja nende valmistamise vahehendid

Country Status (31)

Country Link
US (1) US6667336B2 (da)
EP (1) EP1368336B9 (da)
JP (2) JP2004523548A (da)
KR (1) KR100900020B1 (da)
CN (1) CN1219776C (da)
AT (1) ATE327986T1 (da)
AU (1) AU2002235682C1 (da)
BG (1) BG108164A (da)
BR (1) BR0207307A (da)
CA (1) CA2438367A1 (da)
CY (1) CY1105529T1 (da)
CZ (1) CZ20032503A3 (da)
DE (1) DE60211866T2 (da)
DK (1) DK1368336T3 (da)
EA (1) EA006636B1 (da)
EE (1) EE05329B1 (da)
ES (1) ES2266446T3 (da)
HK (1) HK1061025A1 (da)
HR (1) HRP20030696A2 (da)
HU (1) HUP0303185A3 (da)
IL (1) IL157194A (da)
MX (1) MXPA03007309A (da)
NO (1) NO329038B1 (da)
NZ (1) NZ527695A (da)
PL (1) PL365024A1 (da)
PT (1) PT1368336E (da)
SI (1) SI1368336T1 (da)
SK (1) SK287304B6 (da)
UA (1) UA75114C2 (da)
WO (1) WO2002066456A2 (da)
ZA (1) ZA200307201B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191165B1 (en) * 1996-05-31 2001-02-20 Allelix Neuroscience Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
EP1830833B1 (en) * 2004-12-16 2010-01-27 Janssen Pharmaceutica N.V. Combination of a glycine transporter (glyt1) inhibitor and an antipsychotic for the treatment of symptoms of schizophrenia as well as its preparation and use thereof
WO2008040669A2 (en) * 2006-10-02 2008-04-10 Janssen Pharmaceutica N.V. Novel intermediates for the preparation of a glyt1 inhibitor
WO2008065500A2 (en) * 2006-11-30 2008-06-05 Pfizer Products Inc. Heteroaryl amides as type i glycine transport inhibitors
CN103374057B (zh) * 2012-04-16 2015-08-19 中国医药集团总公司四川抗菌素工业研究所 一种对甘氨酸转运子具有抑制活性的化合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010599A1 (de) 1979-03-22 1980-10-09 Continental Pharma Derivate von glycinamid, deren herstellung und verwendung
BE885303A (fr) 1980-09-19 1981-03-19 Continental Pharma Glycinamides
AU552050B2 (en) 1981-05-26 1986-05-22 Smithkline Beckman Corporation N-substituted azeheterocyclic carboxylic acids and their esters
US4383999A (en) 1981-05-26 1983-05-17 Smithkline Beckman Corporation Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters
US4514414A (en) 1982-10-25 1985-04-30 Smithkline Beckman Corporation N-Substituted pyrrolidineacetic acids and their esters
DK288385D0 (da) 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
FI864246A (fi) 1985-11-08 1987-05-09 Warner Lambert Co N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat.
US4772615A (en) 1985-11-08 1988-09-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
EP0231996B1 (en) 1986-01-07 1993-10-06 Novo Nordisk A/S Novel amino acid derivatives
JPH02129158A (ja) 1988-11-07 1990-05-17 Nippon Steel Corp 光学活性なグリシン誘導体及びその製造方法
IE913279A1 (en) * 1990-09-26 1992-04-08 Astra Ab (2-Thienyl)alkylamine Derivatives Having Neuroprotective¹Properties
ES2036926B1 (es) 1991-08-08 1994-01-16 Uriach & Cia Sa J "procedimiento para la obtencion de derivados de la (2-alquil-3-piridil)metilpiperazina".
WO1997020553A1 (en) 1995-12-07 1997-06-12 Javitt Daniel C Treatment of negative and cognitive symptoms of schizophrenia with glycine uptake antagonists
WO1997045115A1 (en) * 1996-05-31 1997-12-04 Trophix Pharmaceuticals, Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
US6191165B1 (en) 1996-05-31 2001-02-20 Allelix Neuroscience Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
US5922770A (en) * 1996-07-22 1999-07-13 Novo Nordisk A/S Compounds with growth hormone releasing properties
CN1284942A (zh) * 1998-01-09 2001-02-21 辉瑞大药厂 基质金属蛋白酶抑制剂
US6103743A (en) * 1999-08-06 2000-08-15 Allelix Neuroscience, Inc. Unsaturated amino acid derivatives

Also Published As

Publication number Publication date
EE200300394A (et) 2003-12-15
BG108164A (en) 2004-07-30
US20030176489A1 (en) 2003-09-18
AU2002235682C1 (en) 2008-12-11
SK287304B6 (sk) 2010-06-07
NO20033634D0 (no) 2003-08-15
DK1368336T3 (da) 2006-10-02
CZ20032503A3 (cs) 2004-02-18
SK11442003A3 (sk) 2004-03-02
ES2266446T3 (es) 2007-03-01
EP1368336B1 (en) 2006-05-31
HUP0303185A2 (hu) 2003-12-29
HRP20030696A2 (en) 2005-04-30
SI1368336T1 (sl) 2006-10-31
UA75114C2 (en) 2006-03-15
ZA200307201B (en) 2004-07-28
HUP0303185A3 (en) 2008-12-29
IL157194A (en) 2006-12-31
KR20040028719A (ko) 2004-04-03
CN1219776C (zh) 2005-09-21
WO2002066456A2 (en) 2002-08-29
EP1368336B9 (en) 2007-02-14
BR0207307A (pt) 2004-08-17
NZ527695A (en) 2005-05-27
AU2002235682B2 (en) 2007-04-26
CN1491221A (zh) 2004-04-21
CA2438367A1 (en) 2002-08-29
JP2004523548A (ja) 2004-08-05
NO329038B1 (no) 2010-08-02
KR100900020B1 (ko) 2009-06-01
EA200300900A1 (ru) 2004-02-26
MXPA03007309A (es) 2004-06-30
EP1368336A2 (en) 2003-12-10
PT1368336E (pt) 2006-10-31
NO20033634L (no) 2003-10-08
CY1105529T1 (el) 2010-07-28
HK1061025A1 (en) 2004-09-03
US6667336B2 (en) 2003-12-23
EA006636B1 (ru) 2006-02-24
DE60211866T2 (de) 2007-06-14
PL365024A1 (en) 2004-12-27
JP2010059182A (ja) 2010-03-18
ATE327986T1 (de) 2006-06-15
WO2002066456A3 (en) 2002-10-17
DE60211866D1 (de) 2006-07-06

Similar Documents

Publication Publication Date Title
EA200500376A1 (ru) Триазольные производные в качестве ингибиторов трансформирующего фактора роста (tgf)
NO20051008L (no) Nye imidazolforbindelser som transformerende vekst faktor (TGF) inhibitorer
EA200300788A1 (ru) Производные замещенных алкиламинов и их применение
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
MY136430A (en) N-adamantylmethyl derivatives, pharmaceutical compositions containing them and processes for their preparation
EA200500354A1 (ru) Новые оксазольные и тиазольные соединения в качестве ингибиторов трансформирующего фактора роста (тфр)
SE9903544D0 (sv) Novel compounds
EA200500377A1 (ru) Пиразольные производные как ингибиторы трансформирующего фактора роста (tgf)
CY1107747T1 (el) Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης
MXPA04005886A (es) Derivados de azaindolilalquilamina como ligandos de 5-hidroxitirptamina-6.
SE0101932D0 (sv) Pharmaceutical combinations
DOP2002000390A (es) Sal citrato de 5,8 14-hiezatetraciclo [10.3.1.0 2,11. 0.4.9] hexadeca-2(11),3,5,8,9, pentaeno y composiciones farmaceuticas de las mismas
SE0101322D0 (sv) Novel compounds
SE0102716D0 (sv) Novel compounds
DE69917005D1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
MXPA04005809A (es) Inhibidores de proteinas quinasas.
CY1105529T1 (el) Αντικατεστημενα με θειοφαινιο παραγωγα αμυνης σαν glyt-1 αναστολεις
MXPA05010783A (es) Derivados antimicrobianos de [3.1.0] biciclohexilfenil-oxazolidinona y analogos.
ATE274515T1 (de) Pyrazolopyridinderivate
HUP0302255A2 (hu) Szulfonamidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
SE0102058D0 (sv) New Salts II
HUP0303181A2 (hu) 4-Foszfodiészteráz típusú inhibitorok alkalmazása miokardiális betegségek kezelésére alkalmas gyógyszerkészítmények előállítására
HK1083839A1 (en) Indoline compound and medicinal use thereof
SE0100295D0 (sv) New compounds
HN2002000111A (es) Agentes antibacterianos

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20110215